Quincy man becomes first Alzheimer’s patient to try nasal spray drug: ‘I’m hoping like heck’
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
AZFamily14d
Ketamine-derived nasal spray treating Phoenix patients with severe depression
patients sit in a recliner in a therapy room to self-administer the medication under the supervision of a medical provider and three nasal spray devices are used in one two-hour session.
Medical News Today18d
Nasal vestibulitis: Is it a pimple, and what can I do about it?
In the study, scientists used a spray. Nasal vestibulitis is not usually an emergency. However, if a person with a weakened immune system develops a fever, they should go to the emergency room ...
Investopedia18d
Forex Market Hours: Can You Trade 7 Days a Week?
Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Robert Kelly is managing director of XTS Energy LLC, and has more than three ...
WebMD21d
Decongestants and Antihistamines for Colds
Stuffed up? There are many decongestants on the market, but don't use a nasal spray for more than three days. (Photo Credit: iStock/Getty Images) You may prefer decongestants in different ...
India Today22d
US FDA approves new nasal spray for depression treatment: All about it
Spravato has shown to help patients experience improvements in depressive symptoms as early as 24 hours and at 28 days – without the need for daily oral antidepressants. The nasal spray works by ...
healthday23d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ... in depressive symptoms as early as 24 ...
The Daily Beast23d
New Nasal Spray to Treat Depression Gets FDA Approval
Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...
U.S. News & World Report23d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults ... as early as 24 hours and at 28 days -- without ...
Newsweek23d
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug ... neurotransmitter and can reduce symptoms in as little as 24 hours. Johnson & Johnson said that because there are risks of "serious adverse ...
New York Post23d
J&J’s ketamine-derived nasal spray approved by FDA to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions ... in their symptoms as early as 24 hours without the need for daily oral ...
CNN23d
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...